Harnessing the Therapeutic Value of Venetoclax: A Breakthrough Therapy in Acute Myeloid Leukemia

J Clin Oncol. 2021 Sep 1;39(25):2742-2748. doi: 10.1200/JCO.21.00080. Epub 2021 Jun 4.

Authors

Andrew H Wei¹, Gail J Roboz², Hagop M Kantarjian³

Affiliations

¹ Department of Clinical Haematology, Alfred Hospital and Monash University, Melbourne, Victoria, Australia.
² Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY.
³ Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Bridged Bicyclo Compounds, Heterocyclic*
Humans
Leukemia, Myeloid, Acute*
Sulfonamides

Substances

Bridged Bicyclo Compounds, Heterocyclic
Sulfonamides
venetoclax